This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cornell University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Kuldeepsinh Rana: Innovator in Cancer Treatment
Introduction
Kuldeepsinh Rana is a notable inventor based in Lakewood, Colorado. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on utilizing nanoparticles to inhibit metastatic cancer cells, showcasing his commitment to advancing medical science.
Latest Patents
Kuldeepsinh Rana holds a patent for a method to functionalize cells in human blood, other fluids, and tissues using nanoparticles. The patent, titled "Compositions and methods for inhibiting metastatic cancer cells," describes compositions that comprise nanoparticles incorporating leukocyte adhesion molecules and therapeutic molecules on their surface. These nanoparticles can be attached to leukocytes, and their introduction into the circulation of individuals results in the inhibition and reduction of metastatic cancer cells. This groundbreaking approach has the potential to transform cancer treatment.
Career Highlights
Kuldeepsinh Rana is affiliated with Cornell University, where he continues to conduct research and develop innovative solutions in the medical field. His work has garnered attention for its potential impact on cancer therapies and patient outcomes.
Collaborations
Some of his notable coworkers include Michael R. King and Michael J. Mitchell, who have collaborated with him on various research projects. Their combined expertise contributes to the advancement of cancer treatment methodologies.
Conclusion
Kuldeepsinh Rana's innovative work in the field of cancer treatment through the use of nanoparticles highlights his dedication to improving patient care. His contributions are paving the way for new therapeutic approaches in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
